Skip to content
Recent advances in the use of MAPK13 inhibitors for prostate cancel therapy
  • Home
  • Sample Page

Sodium (Epithelial) Channels

  • Home
  • Sodium (Epithelial) Channels

cycloheximide chase assay indicates that RASSF7 destabilized c-Myc protein

Posted by By cahrr September 23, 2021Posted inSodium (Epithelial) Channels
cycloheximide chase assay indicates that RASSF7 destabilized c-Myc protein. Cullin4B-mediated polyubiquitination and degradation. Furthermore, RASSF7 competed with MYC-associated element X (Maximum) in the formation of a heterodimeric complex with c-Myc…
Read More
Recent Posts
  • While these data are in agreement using the function of NBS1 like a sensor of CtIP phosphorylation, the effect was surprising however, since it revealed fundamental differences between your budding candida and human systems
  • For the ABTS, RP, and FRAP assays, water extract exhibited the best activities (3
  • By facilitating the identification of potential markers and targets for combination therapies this tool is intended to make drug development more cost-efficient and increase the likelihood for finding new targets
  • OTX015 was administrated by oral gavage twice daily at 25 mg/kg (35) starting at week 3 (day 21) after bleomycin injury till week 6 (day 42)
  • Following seeding, cells were managed in total EBM-2 MV medium and then treated for overnight with or without 30?M GGA
Recent Comments
  • A WordPress Commenter on Hello world!
Archives
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
Categories
  • SERT
  • SF-1
  • Shp1
  • Shp2
  • Sigma Receptors
  • Signal Transducers and Activators of Transcription
  • Signal Transduction
  • Sir2-like Family Deacetylases
  • Sirtuin
  • Smo Receptors
  • Smoothened Receptors
  • SNSR
  • SOC Channels
  • Sodium Epithelial Channels
  • Sodium NaV Channels
  • Sodium Channels
  • Sodium, Potassium, Chloride Cotransporter
  • Sodium/Calcium Exchanger
  • Sodium/Hydrogen Exchanger
  • Somatostatin sst Receptors
  • Sphingosine Kinase
  • Sphingosine N-acyltransferase
  • Sphingosine-1-Phosphate Receptors
  • sPLA2
  • Src Kinase
  • sst Receptors
  • STAT
  • Stem Cell Dedifferentiation
  • Stem Cell Differentiation
  • Stem Cell Proliferation
  • Stem Cell Signaling
  • Stem Cells
  • Steroid Hormone Receptors
  • STIM-Orai Channels
  • STK-1
  • Syk Kinase
  • Synthases, Other
  • Synthases/Synthetases
  • Synthetase
  • Synthetases, Other
  • T-Type Calcium Channels
  • Tachykinin NK1 Receptors
  • Tachykinin NK2 Receptors
  • Tachykinin NK3 Receptors
  • Tachykinin Receptors
  • Tachykinin, Non-Selective
  • Tau
  • Telomerase
  • TGF-?? Receptors
  • Thrombin
  • Thromboxane A2 Synthetase
  • Thymidylate Synthetase
  • Thyrotropin-Releasing Hormone Receptors
  • TLR
  • TNF-??
  • Toll-like Receptors
  • TP Receptors
  • Transcription Factors
  • Transferases
  • Transforming Growth Factor Beta Receptors
  • Transient Receptor Potential Channels
  • Translocation, Exocytosis & Endocytosis
  • TRH Receptors
  • Trk Receptors
  • TRP Channels
  • TRP Channels, Non-selective
  • TRPA1
  • trpc
  • TRPM
  • TRPML
  • TRPP
  • TRPV
  • Tryptophan Hydroxylase
  • Tubulin
  • Tumor Necrosis Factor-??
  • UBA1
  • Ubiquitin E3 Ligases
  • Ubiquitin proteasome pathway
  • Ubiquitin-activating Enzyme E1
  • Ubiquitin-specific proteases
  • Uncategorized
  • uPA
  • UPP
  • UPS
  • Urease
  • Urokinase-type Plasminogen Activator
  • USP
  • UT Receptor
  • V-Type ATPase
  • V1 Receptors
  • V2 Receptors
  • Vanillioid Receptors
  • Vascular Endothelial Growth Factor Receptors
  • Vasoactive Intestinal Peptide Receptors
  • Vasopressin Receptors
  • VDAC
  • VDR
  • VEGFR
  • Vesicular Monoamine Transporters
  • VIP Receptors
  • Vitamin D Receptors
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright 2023 — Recent advances in the use of MAPK13 inhibitors for prostate cancel therapy. All rights reserved. Sinatra WordPress Theme
Scroll to Top